| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enveric Biosciences, Inc. (ENVB) has 7 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. ENVB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.4K | $200.5K | - | |
| CFO | 47.4K | $135.1K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,360 | $6.51 | $8,853.60 | +1.6% | |
| Jun 28, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 28 | $6.51 | $182.28 | - | |
| Jun 14, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,084 | $6.51 | $7,056.84 | +1.3% | |
| Jun 6, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 804 | $6.51 | $5,234.04 | +0.7% | |
| May 18, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 100 | $6.51 | $651.00 | +0.2% | |
| Apr 20, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 146 | $6.51 | $949.73 | +0.2% | |
| Apr 18, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 73 | $6.51 | $475.23 | +0.2% | |
| Apr 13, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 112 | $6.51 | $729.12 | +0.1% | |
| Apr 4, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 85 | $6.48 | $550.71 | +0.1% | |
| Mar 30, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 127 | $6.51 | $826.77 | - |